Prestige Brands gets U.S. antitrust approval to buy Insight with divestiture
August 28, 2014 at 16:13 PM EDT
WASHINGTON, Aug 28 (Reuters) - Prestige Brands Holdings Inc , which markets and distributes healthcare and cleaning products, has won U.S. antitrust approval to buy Insight Pharmaceuticals Corp on condition that it divest a motion-sickness drug, the Federal Trade Commission said on Thursday.